Differences in risk of herpes zoster infection across medication classes among psoriasis patients: a case-control study

Int J Dermatol. 2023 Jun;62(6):e333-e335. doi: 10.1111/ijd.16305. Epub 2022 Jun 7.

Authors

Alexander J Jafari^{1

2}, Kyle S Owens¹, Shengping Yang³, Lauren H Chen¹, Katherine A Jolin¹, Andrea T Murina¹, Erin E Boh¹

Affiliations

¹ Department of Dermatology, Tulane University School of Medicine, New Orleans, LA, USA.
² Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
³ Department of Biostatistics, Pennington Biomedical Research Center, Baton Rouge, LA, USA.

PMID: 35671391
DOI: 10.1111/ijd.16305

No abstract available

Publication types

Letter

MeSH terms

Case-Control Studies
Herpes Zoster*
Humans
Psoriasis* / complications
Psoriasis* / drug therapy